News-Medical.netGene Therapy as a Potential Cure for Cystic FibrosisNews-Medical.netGene therapy may offer a potential avenue for curing cystic fibrosis through the repair of the defective CFTR gene. The basic idea behind gene therapy is to deliver a f… Continue reading
First-line immunotherapy treatment can improve survival for subset of lung cancer patientsThe Cancer Letter PublicationsFindings from a phase III clinical trial for advanced lung cancer patients could help oncologists better predict which patients are … Continue reading
Bloomberg |
China Regenerative’s Stem Cell Research Sparks Hope
Bloomberg Stem cells can become just about any sort of tissue, if cultivated correctly. With so many potential applications, the companies that perfect the use of stem cells first will stake a claim on massive profits. Hong Kong’s China Regenerative Medicine is … |
Bulletin of the Atomic Scientists |
Better babies through Crispr
Bulletin of the Atomic Scientists Well, thanks to the gene-editing technology Crispr, maybe your chances have just improved. As reported in The New York Times, and originally in the journal Nature, scientists using newly developed Crispr techniques have radically improved their ability … US scientists have corrected a genetic heart mutation in embryos using CRISPRTechCrunch CRISPR Helped ‘Edit’ A Human Embryo — But That’s Not All It Can DoHuffPost Chinese research claiming a gene-editing alternative to CRISPR was just withdrawnQuartz Vox –Newsweek –Chemistry World (subscription) –MIT Technology Review all 373 news articles » |
Richmond.com |
Redskins TE Jordan Reed’s toe injury flared up after a stem–cell treatment
Richmond.com However, after the summer sessions, he got a stem–cell treatment on the toe. “That kind of flared it up a bit on me,” he said. “Now I’m just letting it calm down before I get out there.” Reed hasn’t yet participated in training camp. He visited a … |
|
Cancer Immunotherapy, Part 3: Challenges and Future Trends
P&T Community One major limitation of cancer immunotherapy is the availability of known targetable tumor-specific antigens (TSAs), also called “neoantigens,” that are solely expressed by tumor cells. Tumor-associated antigens, which are expressed by both tumor and … |